A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The goal of this trial is to evaluate the safety and tolerability of lithium in people with
progressive supranuclear palsy or corticobasal degeneration.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Westat
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)